The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Biotechnology


Subject:  Re: DYAI Date:  6/18/2019  2:45 PM
Author:  Cosmid Number:  25122 of 25560

Hey 2K,

While you are looking, I would suggest digging into publication on the C1 system. None listed on their site. Not implying it is invalid, but what have they done to evaluate, for example, fidelity of post-translational modification of the proteins? Are they glycosylated correctly? A fucose here and galactose there and pretty soon you are staring affinity in the face ;-) I can assure you that they are not doing this in-house.

Also, 1% insider ownership is worrisome, especially given what salary the CEO is pulling

Copyright 1996-2021 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us